These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5791799)

  • 1. Demonstration of blood group substance A bound to Pasteurella pestis.
    Luzzio AJ
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):853-8. PubMed ID: 5791799
    [No Abstract]   [Full Text] [Related]  

  • 2. Homogenized anti-plague vaccine prepared on Lupinus seed medium.
    Takla V; Wahba AH; el-Kholy S
    J Egypt Public Health Assoc; 1968; 43(1):13-8. PubMed ID: 5728815
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific identification of fraction I-positive Pasteurella pestis colonies on antiserum-agar plates.
    Albizo JM; Surgalla MJ
    Appl Microbiol; 1968 Apr; 16(4):649-55. PubMed ID: 4871164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISOLATION OF A STRAIN OF PASTEURELLA PSEUDOTUBERCULOSIS FROM ALASKA IDENTIFIED AS PASTEURELLA PESTIS: AN IMMUNOFLUORESCENT FALSE POSITIVE.
    QUAN SF; KNAPP W; GOLDENBERG MI; HUDSON BW; LAWTON WD; CHEN TH; KARTMAN L
    Am J Trop Med Hyg; 1965 May; 14():424-32. PubMed ID: 14292748
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.
    Li B; Jiang L; Song Q; Yang J; Chen Z; Guo Z; Zhou D; Du Z; Song Y; Wang J; Wang H; Yu S; Wang J; Yang R
    Infect Immun; 2005 Jun; 73(6):3734-9. PubMed ID: 15908403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The modifying action of normal human blood serum on vaccinal EV76 and virulent 363(1/1479) strains of Yersinia pestis].
    Ziuzina VP; Tynianova VI; Kravtsov AN; Khodova VA
    Mikrobiol Zh (1978); 1988; 50(5):87-92. PubMed ID: 3249590
    [No Abstract]   [Full Text] [Related]  

  • 7. Agar-gel precipitin-inhibition technique for plague antibody determinations.
    Ray JG; Kadull PJ
    Appl Microbiol; 1965 Nov; 13(6):925-30. PubMed ID: 4956039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IMMUNITY IN PLAGUE. ACQUISITIONS SUPPLIED BY 30 YEARS OF WORK ON THE "PASTEURELLA PESTIS EV" (GIRARD AND ROBIC) STRAIN].
    GIRARD G
    Biol Med (Paris); 1963; 52():631-731. PubMed ID: 14095162
    [No Abstract]   [Full Text] [Related]  

  • 9. [E-antibodies in the sera of animals inoculated against plague and pseudotuberculosis].
    Orlov GS
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):123-4. PubMed ID: 371269
    [No Abstract]   [Full Text] [Related]  

  • 10. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine.
    Bubeck SS; Dube PH
    Clin Vaccine Immunol; 2007 Sep; 14(9):1235-8. PubMed ID: 17652523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [STUDY OF THE VIRULENCE OF PASTEURELLA PESTIS AND PREPARATION OF LIVE VACCINES AGAINST PLAGUE. 3. CHEMICAL STRUCTURE OF PASTEURELLA PESTIS WITH DIFFERENT VIRULENCE].
    MALININA ZE; EGOROVA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Oct; 41():98-102. PubMed ID: 14295829
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survival of EB microbes in live plague vaccine and its immunogeneity in the process of prolonged storage].
    Chicherin IuV; Lebedinskiĭ VA; Evstigneev VI
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):139-40. PubMed ID: 919933
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plague and its agents (current state of our knowledge)].
    Knapp W
    Cah Med; 1970 Jul; 11(9):779-86. PubMed ID: 4989215
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of New Virulence Factors and Vaccine Candidates for
    Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
    Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On stabilization of the immunogenic properties of plague strain EB vaccine by the animalization method].
    Priadkina MD; Zhurba MD
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):16-20. PubMed ID: 4888435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behaviour in vivo of Pasteurella pestis: antigens and antibodies in the pneumonic plague].
    Barber C; Eylan E; Ben-Efraim S
    Rev Immunol (Paris); 1972; 36(4):155-62. PubMed ID: 4667162
    [No Abstract]   [Full Text] [Related]  

  • 18. [On common antigen properties between the human blood group ABO and the pathogen of diseases dangerous for the community. Preliminary report].
    PETTENKOFER HJ; BICKERICH R
    Zentralbl Bakteriol; 1960 Jul; 179():433-6. PubMed ID: 13854323
    [No Abstract]   [Full Text] [Related]  

  • 19. Live-attenuated Yersinia pestis vaccines.
    Wang X; Zhang X; Zhou D; Yang R
    Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Yersinia pestis V antigen in attenuated salmonella typhimurium: development of a novel vaccine for plague.
    Leary SE; Eley SM; Williamson ED; Titball RW
    Contrib Microbiol Immunol; 1995; 13():216-7. PubMed ID: 8833838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.